Dr. Ghassan Abou-Alfa leads a small panel including Dr. Robert Lewandowksi and Dr. Amit Singal in a multidisciplinary discussion of hepatocellular carcinoma and updates to the treatment armamentarium.
EP. 3: Child-Pugh Scoring System and Liver Function AssessmentJanuary 5th 2023
Dr Singal reviews the Child-Pugh scoring system, then Dr Lewandowski discusses the importance of considering liver function as well as disease burden when selecting a treatment strategy.
EP. 8: IMbrave-150 and HIMALAYA: Clinical Trials of Immune Checkpoint Inhibitor Combinations in HCCJanuary 19th 2023
The panel reviews the HIMALAYA and IMbrave-150 clinical trials of checkpoint inhibitor combination therapy strategies in advanced HCC.
EP. 10: Real-World Evidence on Use of Immune Checkpoint Inhibitor Combinations and Clinical Trial EndpointsJanuary 26th 2023
Experts in liver cancer treatment provide insight on real-world trials of immune checkpoint inhibitor combinations in HCC and opine on trial endpoints when immune therapy is utilized.
EP. 11: Novel Strategies: Combining Systemic and Local TherapiesFebruary 2nd 2023
Ghassan Abou-Alfa, MD, Robert Lewandowski, MD, FSIR, and Amit Singal, MD discuss potential novel combination therapies including immune checkpoint inhibitors plus tyrosine kinase inhibitors plus local-regional therapeutic strategies.